HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway.

Abstract
Homocysteine (Hcy) is an independent risk factor for atherosclerosis, which is characterized by lipid accumulation in the atherosclerotic plaque. Increasing evidence supports that as the main receptor of high-density lipoprotein, scavenger receptor class B member 1 (SCARB1) is protective against atherosclerosis. However, the underlying mechanism regarding it in Hcy-mediated atherosclerosis remains unclear. Here, we found the remarkable inhibition of SCARB1 expression in atherosclerotic plaque and Hcy-treated foam cells, whereas overexpression of SCARB1 can suppress lipid accumulation in foam cells following Hcy treatment. Analysis of SCARB1 promoter showed that no significant change of methylation level was observed both in vivo and in vitro under Hcy treatment. Moreover, it was found that the negative regulation of DNMT3b on SCARB1 was due to the decreased recruitment of SP1 to SCARB1 promoter. Thus, we concluded that inhibition of SCARB1 expression induced by DNMT3b at least partly accelerated Hcy-mediated atherosclerosis through promoting lipid accumulation in foam cells, which was attributed to the decreased binding of SP1 to SCARB1 promoter. In our point, these findings will provide novel insight into an epigenetic mechanism for atherosclerosis.
AuthorsWei Guo, Huiping Zhang, Anning Yang, Pengjun Ma, Lei Sun, Mei Deng, Caiyan Mao, Jiantuan Xiong, Jianmin Sun, Nan Wang, Shengchao Ma, Lihong Nie, Yideng Jiang
JournalJournal of molecular and cellular cardiology (J Mol Cell Cardiol) Vol. 138 Pg. 34-48 (01 2020) ISSN: 1095-8584 [Electronic] England
PMID31733201 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 Elsevier Ltd. All rights reserved.
Chemical References
  • Apolipoproteins E
  • CD36 Antigens
  • Sp1 Transcription Factor
  • Homocysteine
  • Methionine
  • DNA (Cytosine-5-)-Methyltransferases
  • DNA methyltransferase 3B
Topics
  • Animals
  • Apolipoproteins E (deficiency, metabolism)
  • Atherosclerosis (complications, metabolism, pathology)
  • CD36 Antigens (metabolism)
  • DNA (Cytosine-5-)-Methyltransferases (metabolism)
  • DNA Methylation (genetics)
  • Diet
  • Disease Progression
  • Down-Regulation (genetics)
  • Foam Cells (metabolism)
  • HEK293 Cells
  • Homocysteine (adverse effects)
  • Humans
  • Hyperhomocysteinemia (complications, pathology)
  • Male
  • Methionine
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Models, Biological
  • Plaque, Atherosclerotic (complications, pathology)
  • Promoter Regions, Genetic
  • Protein Binding
  • Signal Transduction
  • Sp1 Transcription Factor (metabolism)
  • THP-1 Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: